Centro de Investigación en Ciencia Aplicada y Tecnología Avanzada (CICATA), Unidad Morelos

Medicine & Life Sciences

1. Burkholderia pseudomallei 100%
2. Melioidosis 84%
3. Gold 76%
4. Vaccines 75%
5. Nanoparticles 71%
6. Mucosal Immunity 54%
7. Enterohemorrhagic Escherichia coli 51%
8. Burkholderia mallei 49%
9. Glycoconjugates 48%
10. Escherichia coli O157 48%
11. Antigens 42%
12. Virulence Factors 42%
13. Glanders 41%
14. Type VI Secretion Systems 41%
15. Agrocybe 36%
16. Chemokines 32%
17. Infections 30%
18. Laccase 29%
19. Bacterial Outer Membrane 29%
20. Enteropathogenic Escherichia coli 28%
21. Guided Tissue Regeneration 27%
22. benzimidazole 27%
23. Suid Herpesvirus 1 26%
24. Central America 25%
25. Cellular Immunity 25%
26. Herpes Genitalis 25%
27. Trichomonas vaginalis 25%
28. Giardia lamblia 24%
29. polycaprolactone 24%
30. Mucous Membrane 22%
31. RNA-Seq 22%
32. Pets 21%
33. Curcumin 21%
34. Bone Regeneration 21%
35. Gelatin 20%
36. Mexico 20%
37. Humoral Immunity 19%
38. Escherichia coli 19%
39. Isoenzymes 18%
40. Biological Products 18%
41. Communicable Diseases 17%
42. Immunity 17%
43. Burkholderia 17%
44. Epithelial Cells 16%
45. Immunization 15%
46. T-Lymphocyte Subsets 14%
47. T-Lymphocytes 14%
48. Membranes 14%
49. Memory 13%
50. Proteins 13%
51. Anti-Bacterial Agents 13%
52. Enzymes 12%
53. Lipopolysaccharides 12%
54. Parasites 12%
55. Swine 12%
56. Bone and Bones 11%
57. West Indies 10%
58. Animals 9%
59. pyrogallol 1,3-dimethyl ether 9%
60. 6,7-dimethyl-8-ribityllumazine synthase 9%
61. Macrophages 9%
62. Therapeutics 8%
63. Mortality 8%
64. Serum 8%
65. Myeloid Cells 8%
66. 6-phosphogluconolactone 8%
67. Metronidazole 8%
68. Type V Secretion Systems 8%
69. Public Health 8%
70. Virulence 8%
71. In Vitro Techniques 7%
72. Immunoglobulin A 7%
73. Escherichia coli Infections 7%
74. Immunoglobulin G 7%
75. Technology 6%
76. Emerging Communicable Diseases 6%
77. Clinical Studies 6%
78. Escherichia coli Vaccines 6%
79. Disease Reservoirs 6%
80. Serine Proteases 6%
81. Cytokines 6%
82. Enterobacteriaceae 5%
83. Product Recalls and Withdrawals 5%
84. Coronavirus 5%
85. Vaccinology 5%
86. Hemagglutinins 5%
87. Manuscripts 5%
88. Subunit Vaccines 5%
89. Trichomonas Infections 5%
90. Disease Outbreaks 5%
91. Giardiasis 5%
92. Antiparasitic Agents 5%
93. Soil 5%
94. Puerto Rico 5%